Not just another blood test, this is the EKG of coagulation.
The tPA-Challenge™ as a partner assay on the TEG 5000® (and other analyzer platforms) unmasks physiologic decompensation at an earlier time point than conventional viscoelastic assays.
Thus, the tPA-Challenge™ is a valuable new triage tool, able to predict massive hemorrhage in both military and civilian trauma environments.
Physically, the assay is lyophilized protein, stabilizers, and solvation accelerants in an evacuated single-use vile.
Designed to be ergonomically identical to existing assays run on widely adopted partner platforms (e.g. TEG 5000®)
Interpreted using our proprietary stand-alone data-processing software package.
The tPA-Challenge™ is the only in vitro diagnostic assay capable of predicting massive hemorrhage when samples are drawn at the scene-of-injury. There are currently no competing products.
As the tPA-Challenge™ is also more than thirty minutes faster than conventional assays of fibrinolysis, this combined with the ability to analyze scene-of-injury blood, means more than one hour in total time savings to diagnose trauma-induced coagulopathy:
An eternity in the setting of high-acuity trauma resuscitation.
©THROMBO THERAPEUTICS. ALL RIGHTS RESERVED 2019
DESIGNED BY CU DENVER STUDENT AGENCY.